This could be facilitated through fine-mapping studies that better tag causal variants [65] alongside prospective cohort studies examining environmental risk factors in RA cases subdivided by ACPA status, with increasing evidence that risks differ between these serological subsets [36], [66]. Here, PRTN3 is linked to rheumatoid arthritis.